145
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Relationship between the prognostic nutritional index and resistant hypertension in patients with essential hypertension

, &
Pages 326-333 | Received 27 Dec 2021, Accepted 23 Jan 2022, Published online: 18 Feb 2022

References

  • Sinnott SJ, Smeeth L, Williamson E, Douglas IJ. Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015. BMJ. 2017;358(22):j3984. doi:10.1136/bmj.j3984.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Jl I Jr, Jones DW, Materson BJ, Oparil S, Wright JT, et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003 21;289(19):2560–72. doi:10.1001/jama.289.19.2560.
  • Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American heart association professional education committee of the council for high blood pressure research. Hypertension. 2008;51(6):1403–19. doi:10.1161/HYPERTENSIONAHA.108.189141.
  • Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ESC Scientific Document Group. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 1;39(33):3021–104.doi:10.1093/eurheartj/ehy339.
  • Lamirault G, Artifoni M, Daniel M, Barber-Chamoux N, University Hospital Working Group On Hypertension N; Nantes University Hospital Working Group On Hypertension. Resistant Hypertension: novel Insights. Curr Hypertens Rev. 2020;16(1):61–72. 10.2174/1573402115666191011111402.
  • Turkoglu EI, Kircicegi Cıcekdag EC. Resistant hypertension in elderly: a clinical manifestation of heart failure with preserved ejection fraction? Retrospective single-center analysis. Clin Exp Hypertens. 2019;41(6):505–10. doi:10.1080/10641963.2018.1510945. PMID: 30183433.
  • Alagacone S, Verga E, Verdolini R, Saifullah SM. The association between vitamin D deficiency and the risk of resistant hypertension. Clin Exp Hypertens. 2020;42(2):177–80. doi:10.1080/10641963.2019.1601204
  • Romano S, Idolazzi C, Fava C, Fondrieschi L, Celebrano M, Delva P, Branz L, Donato A, Dalbeni A, Minuz P, et al. Prevalence and Comorbidities of resistant hypertension: a collaborative population-based observational study. High Blood Press Cardiovasc Prev. 2018;25(3):295–301. doi:10.1007/s40292-018-0268-x.
  • Grassi G, Cifkova R, Laurent S, Narkiewicz K, Redon J, Farsang C, Viigimaa M, Erdine S, Brambilla G, Bombelli M, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and Eastern European countries: results of the BP-CARE study. Eur Heart J. 2011;32(2):218–25. doi:10.1093/eurheartj/ehq394.
  • Korhonen PE, Kautiainen H, Kantola I. Patients with resistant hypertension have more peripheral arterial disease than other uncontrolled hypertensives. J Hum Hypertens. 2015;29(1):46–49. doi:10.1038/jhh.2014.65
  • Pioli MR, de Faria AP. Pro-inflammatory cytokines and resistant hypertension: potential for novel treatments? Curr Hypertens Rep. 2019 26;21(12):95. doi:10.1007/s11906-019-1003-2. PMID: 31773311.
  • Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–05.
  • Chen QJ, Qu HJ, Li DZ, Li XM, Zhu JJ, Xiang Y, Li L, Ma Y-T, and Yang Y-N, Prognostic nutritional index predicts clinical outcome in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Sci Rep. 2017 Jun 12;7(1):3285. doi:10.1038/s41598-017-03364-x.
  • Zencirkiran Agus H, Kahraman S. Prognostic nutritional index predicts one-year outcome in heart failure with preserved ejection fraction. Acta Cardiol. 2020;75(5):450–55. doi:10.1080/00015385.2019.1661139
  • Cheng YL, Sung SH, Cheng HM, Hsu PF, Guo CY, Yu WC, and Chen C-H, Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(e004876). doi:10.1161/JAHA.116.004876
  • Scrutinio D, Lanzillo B, Guida P, Passantino A, Spaccavento S, Battista P. Association between malnutrition and outcomes in patients with severe ischemic stroke undergoing rehabilitation. Arch Phys Med Rehabil. 2020;101(5):852–60. doi:10.1016/j.apmr.2019.11.012
  • Dolapoglu A, Avci E, Kiris T, Bugra O. The predictive value of the prognostic nutritional index for postoperative acute kidney injury in patients undergoing on-pump coronary bypass surgery. J Cardiothorac Surg. 2019 11;14(1):74. doi:10.1186/s13019-019-0898-7.
  • Min JY, Woo A, Chae MS, Hong SH, Park CS, Choi JH, and Chung HS, Predictive impact of modified-prognostic nutritional index for acute kidney injury within 1-week after living donor liver transplantation. Int J Med Sci. 2020 1;17(1):82–88. doi:10.7150/ijms.39014.
  • Barutcu Atas D, Tugcu M, Asicioglu E, Velioglu A, Arikan H, Koc M, Tuglular S. Prognostic nutritional index is a predictor of mortality in elderly patients with chronic kidney disease. Int Urol Nephrol. 2021; Epub ahead of print. 25. doi:10.1007/s11255-021-03002-6.
  • Chen J, Bundy JD, Hamm LL, Hsu CY, Lash J, Miller ER 3rd, Thomas G, Cohen DL, Weir MR, Raj DS, et al. Inflammation and apparent treatment-resistant hypertension in patients with chronic kidney disease. Hypertension. 2019;73(4):785–93. doi:10.1161/HYPERTENSIONAHA.118.12358.
  • Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, and Schiffrin EL, Regulatory Lymphocytes T. 2011. Prevent Angiotensin II–Induced hypertension and vascular injury. Hypertension. 2011;57(3):469–76. doi:10.1161/HYPERTENSIONAHA.110.162941.
  • Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, and Cincin A, Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens. 2014;36(4):217–21. doi:10.3109/10641963.2013.804547.
  • Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28(8):463–68. doi:10.1038/jhh.2013.140
  • Yılmaz AS, Ergül E, Çırakoğlu ÖF, Emlek N, Çetin M. Prognostic nutritional index is related to myocardial performance index in newly diagnosed nondiabetic hypertensive patients. Clin Exp Hypertens. 2021 19;43(4):378–83. doi:10.1080/10641963.2021.1890767.
  • Belen E, Şahin İ, Güngör B, Ayça B, Avcı İİ, Avşar M, Yıldız SS, Akın F, Bozbeyoglu E, Okuyan E, et al. Assessment of 25-Hydroxyvitamin D levels in patients with resistant hypertension. Med Princ Pract. 2016;25(1):25–30. doi:10.1159/000437227.
  • Barbaro NR, Fontana V, Modolo R, De Faria AP, Sabbatini AR, Fonseca FH, Anhê GF, and Moreno H, Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. Blood Press. 2015;24(1):7–13. doi:10.3109/08037051.2014.940710.
  • Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, De Luca, N, Fallo, F, Ferri, C, Mancia, G, et al. Italian Society of Hypertension. Renal artery denervation for treating resistant hypertension: definition of the disease, patient selection and description of the procedure. High Blood Press Cardiovasc Prev. 2012;19(4):237–44. doi:10.1007/BF03297636.
  • Volpe M, Tocci G. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice. Expert Rev Cardiovasc Ther. 2010 Jun;8(6):811–20. doi:10.1586/erc.10.47.
  • Grassi G, Bombelli M, Seravalle G, Brambilla G, Dell’oro R, Mancia G. Role of ambulatory blood pressure monitoring in resistant hypertension. Curr Hypertens Rep. 2013;15(3):232–37. doi:10.1007/s11906-013-0349-0
  • Persu A, O’Brien E, Verdecchia P. Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence. Hypertens Res. 2014;37(11):967–72. doi:10.1038/hr.2014.83
  • Lazaridis AA, Sarafidis PA, Ruilope LM. Ambulatory blood pressure monitoring in the diagnosis, prognosis, and management of resistant hypertension: still a matter of our resistance? Curr Hypertens Rep. 2015;17(10):78. doi:10.1007/s11906-015-0590-9
  • Oliveras A, de la Sierra A. Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes. J Hum Hypertens. 2014;28(4):213–17. doi:10.1038/jhh.2013.77
  • Bolat I, Pusuroglu H, Demir AR, Ornek V, Erturk M. Decreased neurotensin levels as a biomarker in resistant hypertension. Clin Exp Hypertens. 2020;42(3):266–70. doi:10.1080/10641963.2019.1632340. PMID: 31204518.
  • Cortez AF, Muxfeldt ES, Cardoso CR, Salles GF. Prognostic Value of C-Reactive Protein in Resistant Hypertension. Am J Hypertens. 2016;29(8):992–1000. doi:10.1093/ajh/hpw011
  • Targonski R, Sadowski J, Price S, Targonski R. Sodium-induced inflammation-an invisible player in resistant hypertension. Hypertens Res. 2020;43(7):629–33.doi:10.1038/s41440-020-0428-y.
  • Oliveras A, Armario P, Hernández-Del Rey R, Arroyo JA, Poch E, Larrousse M, Roca-Cusachs, A, de la Sierra, A, Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens. 2010;24(1):27–33. doi:10.1038/jhh.2009.35.
  • Galletti F, Barbato A, MINISAL-SIIA Study Group. Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program. J Hum Hypertens. 2016;30(11):703–08. doi:10.1038/jhh.2016.6.
  • Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:10.1016/j.ejim.2018.04.014.
  • Hostmark AT, Tomten SE, Berg JE. Serum albumin and blood pressure: a population-based, cross-sectional study. J Hypertens. 2005;23(4):725–30.doi:10.1097/01.hjh.0000163139.44094.1d.
  • Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest. 1990;85(1):248–55. doi:10.1172/JCI114419
  • Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12(5):1179–86. doi:10.1002/hep.1840120517
  • Amador CA, Barrientos V, Pena J, Herrada AA, Gonzalez M, Valdes S, Carrasco L, Alzamora R, Figueroa F, Kalergis AM, et al. Spironolactone. Hypertension. 2014;63(4):797–803.doi:10.1161/HYPERTENSIONAHA.113.02883.
  • Fulop T, Rule AD, Schmidt DW, Wiste HJ, Bailey KR, Kullo IJ, Schwartz, GL, Mosley , TH, Boerwinkle, E, Turner, ST, C-reactive protein among community-dwelling hypertensives on single-agent antihypertensive treatment. J Am Soc Hypertens. 2009;3(4):260–66. doi:10.1016/j.jash.2009.03.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.